SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,729.27 413.66
( 0.56%)

Global Indices

Nasdaq

52,191.76 549.28
(1.06%)

Dow Jones

7,764.37 24.43
(0.32%)

Hang Seng

65,489.63 1,063.68
(1.65%)

Nikkei 225

10,840.19 115.33
(1.08%)

Forex

USD-INR

95.08 -0.14
(-0.15%)

EUR-INR

106.23 -0.27
(-0.26%)

GBP-INR

125.74 -0.30
(-0.24%)

JPY-INR

0.60 0.00
(-0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Albert David Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524075

INE155C01010

685.7077058

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ALBERTDAVD

19.95

450.09

EPS(TTM)

Face Value()

Div & Yield %

39.52

0.63

Back

Albert David standalone net profit rises 303.02% in the June 2026 quarter

Aug 06,2026

Net profit of Albert David rose 303.02% to Rs 32.00 crore in the quarter ended June 2026 as against Rs 7.94 crore during the previous quarter ended June 2025. Sales rose 43.60% to Rs 101.34 crore in the quarter ended June 2026 as against Rs 70.57 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	101.34	70.57	44
OPM %	10.51	-15.11	-
PBDT	38.09	10.83	252
PBT	35.80	8.44	324
NP	32.00	7.94	303

74,729.27 413.66 ( 0.56%)

52,191.76 549.28 (1.06%)

7,764.37 24.43 (0.32%)

65,489.63 1,063.68 (1.65%)

10,840.19 115.33 (1.08%)

95.08 -0.14 (-0.15%)

106.23 -0.27 (-0.26%)

125.74 -0.30 (-0.24%)

0.60 0.00 (-0.23%)